ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Methylphenidate Hydrochloride Extended-Release Tablets Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-2S19220
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Methylphenidate Hydrochloride Extended Release Tablets Market Research Report 2025
BUY CHAPTERS

Global Methylphenidate Hydrochloride Extended-Release Tablets Market Research Report 2025

Code: QYRE-Auto-2S19220
Report
March 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CNS
Janssen Pharmaceuticals
Tris Pharma
Novartis
Mallinckrodt Pharmaceuticals
UCB
Mylan NV
Suzhou No.1 Pharmaceutical
Pediatrix Therapeutics

Methylphenidate Hydrochloride Extended-Release Tablets Market Size

The global market for Methylphenidate Hydrochloride Extended-Release Tablets was valued at US$ 510 million in the year 2024 and is projected to reach a revised size of US$ 678 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Methylphenidate Hydrochloride Extended-Release Tablets Market

Methylphenidate Hydrochloride Extended-Release Tablets Market

Methylphenidate Hydrochloride Extended-Release Tablets are a type of medication commonly used in the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) and Narcolepsy. Methylphenidate is a central nervous system (CNS) stimulant, and the extended-release formulation is designed to provide a gradual release of the active ingredient over an extended period, helping to maintain more stable blood levels and reduce the need for multiple doses throughout the day.
North American market for Methylphenidate Hydrochloride Extended-Release Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Methylphenidate Hydrochloride Extended-Release Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Methylphenidate Hydrochloride Extended-Release Tablets include Janssen Pharmaceuticals, Suzhou No.1 Pharmaceutical, Tris Pharma, Pediatrix Therapeutics, Novartis, Mallinckrodt Pharmaceuticals, UCB, Mylan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Methylphenidate Hydrochloride Extended-Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methylphenidate Hydrochloride Extended-Release Tablets.
The Methylphenidate Hydrochloride Extended-Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Methylphenidate Hydrochloride Extended-Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methylphenidate Hydrochloride Extended-Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Methylphenidate Hydrochloride Extended-Release Tablets Market Report

Report Metric Details
Report Name Methylphenidate Hydrochloride Extended-Release Tablets Market
Accounted market size in year US$ 510 million
Forecasted market size in 2031 US$ 678 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 18mg
  • 36mg
  • 54mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Janssen Pharmaceuticals, Suzhou No.1 Pharmaceutical, Tris Pharma, Pediatrix Therapeutics, Novartis, Mallinckrodt Pharmaceuticals, UCB, Mylan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Methylphenidate Hydrochloride Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Methylphenidate Hydrochloride Extended-Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Methylphenidate Hydrochloride Extended-Release Tablets Market growing?

Ans: The Methylphenidate Hydrochloride Extended-Release Tablets Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Methylphenidate Hydrochloride Extended-Release Tablets Market size in 2031?

Ans: The Methylphenidate Hydrochloride Extended-Release Tablets Market size in 2031 will be US$ 678 million.

Who are the main players in the Methylphenidate Hydrochloride Extended-Release Tablets Market report?

Ans: The main players in the Methylphenidate Hydrochloride Extended-Release Tablets Market are Janssen Pharmaceuticals, Suzhou No.1 Pharmaceutical, Tris Pharma, Pediatrix Therapeutics, Novartis, Mallinckrodt Pharmaceuticals, UCB, Mylan

What are the Application segmentation covered in the Methylphenidate Hydrochloride Extended-Release Tablets Market report?

Ans: The Applications covered in the Methylphenidate Hydrochloride Extended-Release Tablets Market report are Hospital, Clinic, Pharmacy

What are the Type segmentation covered in the Methylphenidate Hydrochloride Extended-Release Tablets Market report?

Ans: The Types covered in the Methylphenidate Hydrochloride Extended-Release Tablets Market report are 18mg, 36mg, 54mg

Recommended Reports

ADHD and CNS Drugs

Hydrochloride Formulations

Neurological Disorders Therapy

1 Methylphenidate Hydrochloride Extended-Release Tablets Market Overview
1.1 Product Definition
1.2 Methylphenidate Hydrochloride Extended-Release Tablets by Type
1.2.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 18mg
1.2.3 36mg
1.2.4 54mg
1.3 Methylphenidate Hydrochloride Extended-Release Tablets by Application
1.3.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Methylphenidate Hydrochloride Extended-Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue 2020-2031
1.4.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales 2020-2031
1.4.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Methylphenidate Hydrochloride Extended-Release Tablets Market Competition by Manufacturers
2.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Methylphenidate Hydrochloride Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Methylphenidate Hydrochloride Extended-Release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Methylphenidate Hydrochloride Extended-Release Tablets, Product Type & Application
2.7 Global Key Manufacturers of Methylphenidate Hydrochloride Extended-Release Tablets, Date of Enter into This Industry
2.8 Global Methylphenidate Hydrochloride Extended-Release Tablets Market Competitive Situation and Trends
2.8.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Methylphenidate Hydrochloride Extended-Release Tablets Players Market Share by Revenue
2.8.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Methylphenidate Hydrochloride Extended-Release Tablets Market Scenario by Region
3.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Region: 2020-2031
3.2.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Region: 2020-2025
3.2.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Region: 2026-2031
3.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region: 2020-2031
3.3.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region: 2020-2025
3.3.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region: 2026-2031
3.4 North America Methylphenidate Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
3.4.1 North America Methylphenidate Hydrochloride Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2020-2031)
3.4.3 North America Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Methylphenidate Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
3.5.1 Europe Methylphenidate Hydrochloride Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2020-2031)
3.5.3 Europe Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Methylphenidate Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Methylphenidate Hydrochloride Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2020-2031)
3.7.3 Latin America Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Type (2020-2031)
4.1.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Type (2020-2025)
4.1.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Type (2026-2031)
4.1.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Type (2020-2031)
4.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Type (2020-2031)
4.2.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Type (2020-2025)
4.2.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Type (2026-2031)
4.2.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Application (2020-2031)
5.1.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Application (2020-2025)
5.1.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Application (2026-2031)
5.1.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Application (2020-2031)
5.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Application (2020-2031)
5.2.1 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Application (2020-2025)
5.2.2 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Application (2026-2031)
5.2.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Methylphenidate Hydrochloride Extended-Release Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Janssen Pharmaceuticals
6.1.1 Janssen Pharmaceuticals Company Information
6.1.2 Janssen Pharmaceuticals Description and Business Overview
6.1.3 Janssen Pharmaceuticals Methylphenidate Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Janssen Pharmaceuticals Methylphenidate Hydrochloride Extended-Release Tablets Product Portfolio
6.1.5 Janssen Pharmaceuticals Recent Developments/Updates
6.2 Suzhou No.1 Pharmaceutical
6.2.1 Suzhou No.1 Pharmaceutical Company Information
6.2.2 Suzhou No.1 Pharmaceutical Description and Business Overview
6.2.3 Suzhou No.1 Pharmaceutical Methylphenidate Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Suzhou No.1 Pharmaceutical Methylphenidate Hydrochloride Extended-Release Tablets Product Portfolio
6.2.5 Suzhou No.1 Pharmaceutical Recent Developments/Updates
6.3 Tris Pharma
6.3.1 Tris Pharma Company Information
6.3.2 Tris Pharma Description and Business Overview
6.3.3 Tris Pharma Methylphenidate Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Tris Pharma Methylphenidate Hydrochloride Extended-Release Tablets Product Portfolio
6.3.5 Tris Pharma Recent Developments/Updates
6.4 Pediatrix Therapeutics
6.4.1 Pediatrix Therapeutics Company Information
6.4.2 Pediatrix Therapeutics Description and Business Overview
6.4.3 Pediatrix Therapeutics Methylphenidate Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pediatrix Therapeutics Methylphenidate Hydrochloride Extended-Release Tablets Product Portfolio
6.4.5 Pediatrix Therapeutics Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Methylphenidate Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Methylphenidate Hydrochloride Extended-Release Tablets Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Mallinckrodt Pharmaceuticals
6.6.1 Mallinckrodt Pharmaceuticals Company Information
6.6.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.6.3 Mallinckrodt Pharmaceuticals Methylphenidate Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mallinckrodt Pharmaceuticals Methylphenidate Hydrochloride Extended-Release Tablets Product Portfolio
6.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.7 UCB
6.7.1 UCB Company Information
6.7.2 UCB Description and Business Overview
6.7.3 UCB Methylphenidate Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 UCB Methylphenidate Hydrochloride Extended-Release Tablets Product Portfolio
6.7.5 UCB Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Company Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Methylphenidate Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mylan Methylphenidate Hydrochloride Extended-Release Tablets Product Portfolio
6.8.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Methylphenidate Hydrochloride Extended-Release Tablets Industry Chain Analysis
7.2 Methylphenidate Hydrochloride Extended-Release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Methylphenidate Hydrochloride Extended-Release Tablets Production Mode & Process Analysis
7.4 Methylphenidate Hydrochloride Extended-Release Tablets Sales and Marketing
7.4.1 Methylphenidate Hydrochloride Extended-Release Tablets Sales Channels
7.4.2 Methylphenidate Hydrochloride Extended-Release Tablets Distributors
7.5 Methylphenidate Hydrochloride Extended-Release Tablets Customer Analysis
8 Methylphenidate Hydrochloride Extended-Release Tablets Market Dynamics
8.1 Methylphenidate Hydrochloride Extended-Release Tablets Industry Trends
8.2 Methylphenidate Hydrochloride Extended-Release Tablets Market Drivers
8.3 Methylphenidate Hydrochloride Extended-Release Tablets Market Challenges
8.4 Methylphenidate Hydrochloride Extended-Release Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CNS
Janssen Pharmaceuticals
Tris Pharma
Novartis
Mallinckrodt Pharmaceuticals
UCB
Mylan NV
Suzhou No.1 Pharmaceutical
Pediatrix Therapeutics
List of Tables
 Table 1. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Methylphenidate Hydrochloride Extended-Release Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Methylphenidate Hydrochloride Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Methylphenidate Hydrochloride Extended-Release Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Methylphenidate Hydrochloride Extended-Release Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Methylphenidate Hydrochloride Extended-Release Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Methylphenidate Hydrochloride Extended-Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylphenidate Hydrochloride Extended-Release Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Region (2020-2025) & (Units)
 Table 18. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales by Region (2026-2031) & (Units)
 Table 20. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2020-2025) & (Units)
 Table 27. North America Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2026-2031) & (Units)
 Table 28. North America Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2020-2025) & (Units)
 Table 32. Europe Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2026-2031) & (Units)
 Table 33. Europe Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units) by Type (2020-2025)
 Table 51. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units) by Type (2026-2031)
 Table 52. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Methylphenidate Hydrochloride Extended-Release Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Methylphenidate Hydrochloride Extended-Release Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units) by Application (2020-2025)
 Table 61. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units) by Application (2026-2031)
 Table 62. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Methylphenidate Hydrochloride Extended-Release Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Methylphenidate Hydrochloride Extended-Release Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. Janssen Pharmaceuticals Company Information
 Table 71. Janssen Pharmaceuticals Description and Business Overview
 Table 72. Janssen Pharmaceuticals Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Janssen Pharmaceuticals Methylphenidate Hydrochloride Extended-Release Tablets Product
 Table 74. Janssen Pharmaceuticals Recent Developments/Updates
 Table 75. Suzhou No.1 Pharmaceutical Company Information
 Table 76. Suzhou No.1 Pharmaceutical Description and Business Overview
 Table 77. Suzhou No.1 Pharmaceutical Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Suzhou No.1 Pharmaceutical Methylphenidate Hydrochloride Extended-Release Tablets Product
 Table 79. Suzhou No.1 Pharmaceutical Recent Developments/Updates
 Table 80. Tris Pharma Company Information
 Table 81. Tris Pharma Description and Business Overview
 Table 82. Tris Pharma Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Tris Pharma Methylphenidate Hydrochloride Extended-Release Tablets Product
 Table 84. Tris Pharma Recent Developments/Updates
 Table 85. Pediatrix Therapeutics Company Information
 Table 86. Pediatrix Therapeutics Description and Business Overview
 Table 87. Pediatrix Therapeutics Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pediatrix Therapeutics Methylphenidate Hydrochloride Extended-Release Tablets Product
 Table 89. Pediatrix Therapeutics Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis Methylphenidate Hydrochloride Extended-Release Tablets Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Mallinckrodt Pharmaceuticals Company Information
 Table 96. Mallinckrodt Pharmaceuticals Description and Business Overview
 Table 97. Mallinckrodt Pharmaceuticals Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Mallinckrodt Pharmaceuticals Methylphenidate Hydrochloride Extended-Release Tablets Product
 Table 99. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 100. UCB Company Information
 Table 101. UCB Description and Business Overview
 Table 102. UCB Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. UCB Methylphenidate Hydrochloride Extended-Release Tablets Product
 Table 104. UCB Recent Developments/Updates
 Table 105. Mylan Company Information
 Table 106. Mylan Description and Business Overview
 Table 107. Mylan Methylphenidate Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Mylan Methylphenidate Hydrochloride Extended-Release Tablets Product
 Table 109. Mylan Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Methylphenidate Hydrochloride Extended-Release Tablets Distributors List
 Table 113. Methylphenidate Hydrochloride Extended-Release Tablets Customers List
 Table 114. Methylphenidate Hydrochloride Extended-Release Tablets Market Trends
 Table 115. Methylphenidate Hydrochloride Extended-Release Tablets Market Drivers
 Table 116. Methylphenidate Hydrochloride Extended-Release Tablets Market Challenges
 Table 117. Methylphenidate Hydrochloride Extended-Release Tablets Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Methylphenidate Hydrochloride Extended-Release Tablets
 Figure 2. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Share by Type: 2024 & 2031
 Figure 4. 18mg Product Picture
 Figure 5. 36mg Product Picture
 Figure 6. 54mg Product Picture
 Figure 7. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Pharmacy
 Figure 12. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Methylphenidate Hydrochloride Extended-Release Tablets Sales (2020-2031) & (Units)
 Figure 15. Global Methylphenidate Hydrochloride Extended-Release Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 16. Methylphenidate Hydrochloride Extended-Release Tablets Report Years Considered
 Figure 17. Methylphenidate Hydrochloride Extended-Release Tablets Sales Share by Manufacturers in 2024
 Figure 18. Global Methylphenidate Hydrochloride Extended-Release Tablets Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Methylphenidate Hydrochloride Extended-Release Tablets Players: Market Share by Revenue in Methylphenidate Hydrochloride Extended-Release Tablets in 2024
 Figure 20. Methylphenidate Hydrochloride Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Methylphenidate Hydrochloride Extended-Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Country (2020-2031)
 Figure 23. North America Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2020-2031)
 Figure 24. United States Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Country (2020-2031)
 Figure 27. Europe Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Region (2020-2031)
 Figure 35. China Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Colombia Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Methylphenidate Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Methylphenidate Hydrochloride Extended-Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Methylphenidate Hydrochloride Extended-Release Tablets by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Methylphenidate Hydrochloride Extended-Release Tablets by Type (2020-2031)
 Figure 55. Global Methylphenidate Hydrochloride Extended-Release Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Methylphenidate Hydrochloride Extended-Release Tablets by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Methylphenidate Hydrochloride Extended-Release Tablets by Application (2020-2031)
 Figure 58. Global Methylphenidate Hydrochloride Extended-Release Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 59. Methylphenidate Hydrochloride Extended-Release Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Metformin Hydrochloride Sustained release Tablets Market Research Report 2024
Global Donepezil Hydrochloride Tablets Market Research Report 2024
Global Dihexyphenidyl Hydrochloride Tablets Market Research Report 2024
Global Methylphenidate Extended Release Tablets Market Research Report 2024
Global Methylphenidate for ADHD Treatment Market Research Report 2024
Global Methylphenidate Hydrochloride Market Research Report 2024
Methylphenidate Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atomoxetine Hydrochloride Capsules Market Research Report 2024
Global ADHD Drug Treatment Market Research Report 2024
Global Bupropion Hydrochloride Extended Release Tablets Market Research Report 2025
Global Methylphenidate Transdermal Patches Market Research Report 2025
Global Chlorpromazine Hydrochloride Tablets Market Research Report 2025
Extended release Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult ADHD Treatment Market Research Report 2024
Global Guanfacine Extended Release Pill Market Research Report 2024
Attention Deficit Hyperactivity Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ephedrine Hydrochloride Tablets Market Research Report 2024
ADHD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ADHD Medications Market Insights Forecast to 2030
Metformin Hydrochloride Sustained release Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions